ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders

Rathan M. Subramaniam, Kirk A. Frey, Christopher H. Hunt, Gustavo A. Mercier, Lilja B. Solnes, Patrick M. Colletti, Yang Lu, Bital Savir-Baruch, Hadyn T. Williams

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This American College of Radiology and American College of Nuclear Medicine joint clinical practice parameter is for performance of dopamine transporter single photon emission computed tomography (SPECT) imaging, for patients with movement disorders. Parkinsonian syndrome (PS) consists of a group of neurodegenerative diseases including Parkinson disease (PD), progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and dementia with Lewy bodies (DLB). Accurate diagnosis of PS is critical for clinical management. An important diagnostic dilemma is the differentiation of PS and non-neurodegenerative disorders, such as essential tremor (ET) or drug-induced tremor, due to the overlap of clinical symptoms. The management approach to these conditions is distinctly different. An abnormal iodine-123 ioflupane SPECT scan suggests a decreased amount of dopamine transporter in the striatum, that is, a diagnosis of nigrostriatal neurodegenerative PS, whereas a normal scan suggests ET or other nondegenerative parkinsonism (drug-induced, vascular, or psychogenic).

Original languageEnglish (US)
Pages (from-to)847-852
Number of pages6
JournalClinical Nuclear Medicine
Volume42
Issue number11
DOIs
StatePublished - Nov 1 2017

Fingerprint

Dopamine Plasma Membrane Transport Proteins
Movement Disorders
Parkinsonian Disorders
Single-Photon Emission-Computed Tomography
Essential Tremor
Essential Drugs
Progressive Supranuclear Palsy
Multiple System Atrophy
Lewy Body Disease
Nuclear Medicine
Tremor
Radiology
Iodine
Neurodegenerative Diseases
Blood Vessels
Parkinson Disease
Joints
Pharmaceutical Preparations

Keywords

  • ACR practice parameter
  • dopamine transporter SPECT
  • essential tremor
  • movement disorders
  • parkinsonian syndromes

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders. / Subramaniam, Rathan M.; Frey, Kirk A.; Hunt, Christopher H.; Mercier, Gustavo A.; Solnes, Lilja B.; Colletti, Patrick M.; Lu, Yang; Savir-Baruch, Bital; Williams, Hadyn T.

In: Clinical Nuclear Medicine, Vol. 42, No. 11, 01.11.2017, p. 847-852.

Research output: Contribution to journalArticle

Subramaniam, RM, Frey, KA, Hunt, CH, Mercier, GA, Solnes, LB, Colletti, PM, Lu, Y, Savir-Baruch, B & Williams, HT 2017, 'ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders', Clinical Nuclear Medicine, vol. 42, no. 11, pp. 847-852. https://doi.org/10.1097/RLU.0000000000001815
Subramaniam, Rathan M. ; Frey, Kirk A. ; Hunt, Christopher H. ; Mercier, Gustavo A. ; Solnes, Lilja B. ; Colletti, Patrick M. ; Lu, Yang ; Savir-Baruch, Bital ; Williams, Hadyn T. / ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders. In: Clinical Nuclear Medicine. 2017 ; Vol. 42, No. 11. pp. 847-852.
@article{869cb30816d54a7482be8ea34fcd3646,
title = "ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders",
abstract = "This American College of Radiology and American College of Nuclear Medicine joint clinical practice parameter is for performance of dopamine transporter single photon emission computed tomography (SPECT) imaging, for patients with movement disorders. Parkinsonian syndrome (PS) consists of a group of neurodegenerative diseases including Parkinson disease (PD), progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and dementia with Lewy bodies (DLB). Accurate diagnosis of PS is critical for clinical management. An important diagnostic dilemma is the differentiation of PS and non-neurodegenerative disorders, such as essential tremor (ET) or drug-induced tremor, due to the overlap of clinical symptoms. The management approach to these conditions is distinctly different. An abnormal iodine-123 ioflupane SPECT scan suggests a decreased amount of dopamine transporter in the striatum, that is, a diagnosis of nigrostriatal neurodegenerative PS, whereas a normal scan suggests ET or other nondegenerative parkinsonism (drug-induced, vascular, or psychogenic).",
keywords = "ACR practice parameter, dopamine transporter SPECT, essential tremor, movement disorders, parkinsonian syndromes",
author = "Subramaniam, {Rathan M.} and Frey, {Kirk A.} and Hunt, {Christopher H.} and Mercier, {Gustavo A.} and Solnes, {Lilja B.} and Colletti, {Patrick M.} and Yang Lu and Bital Savir-Baruch and Williams, {Hadyn T.}",
year = "2017",
month = "11",
day = "1",
doi = "10.1097/RLU.0000000000001815",
language = "English (US)",
volume = "42",
pages = "847--852",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders

AU - Subramaniam, Rathan M.

AU - Frey, Kirk A.

AU - Hunt, Christopher H.

AU - Mercier, Gustavo A.

AU - Solnes, Lilja B.

AU - Colletti, Patrick M.

AU - Lu, Yang

AU - Savir-Baruch, Bital

AU - Williams, Hadyn T.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - This American College of Radiology and American College of Nuclear Medicine joint clinical practice parameter is for performance of dopamine transporter single photon emission computed tomography (SPECT) imaging, for patients with movement disorders. Parkinsonian syndrome (PS) consists of a group of neurodegenerative diseases including Parkinson disease (PD), progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and dementia with Lewy bodies (DLB). Accurate diagnosis of PS is critical for clinical management. An important diagnostic dilemma is the differentiation of PS and non-neurodegenerative disorders, such as essential tremor (ET) or drug-induced tremor, due to the overlap of clinical symptoms. The management approach to these conditions is distinctly different. An abnormal iodine-123 ioflupane SPECT scan suggests a decreased amount of dopamine transporter in the striatum, that is, a diagnosis of nigrostriatal neurodegenerative PS, whereas a normal scan suggests ET or other nondegenerative parkinsonism (drug-induced, vascular, or psychogenic).

AB - This American College of Radiology and American College of Nuclear Medicine joint clinical practice parameter is for performance of dopamine transporter single photon emission computed tomography (SPECT) imaging, for patients with movement disorders. Parkinsonian syndrome (PS) consists of a group of neurodegenerative diseases including Parkinson disease (PD), progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and dementia with Lewy bodies (DLB). Accurate diagnosis of PS is critical for clinical management. An important diagnostic dilemma is the differentiation of PS and non-neurodegenerative disorders, such as essential tremor (ET) or drug-induced tremor, due to the overlap of clinical symptoms. The management approach to these conditions is distinctly different. An abnormal iodine-123 ioflupane SPECT scan suggests a decreased amount of dopamine transporter in the striatum, that is, a diagnosis of nigrostriatal neurodegenerative PS, whereas a normal scan suggests ET or other nondegenerative parkinsonism (drug-induced, vascular, or psychogenic).

KW - ACR practice parameter

KW - dopamine transporter SPECT

KW - essential tremor

KW - movement disorders

KW - parkinsonian syndromes

UR - http://www.scopus.com/inward/record.url?scp=85032866321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032866321&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000001815

DO - 10.1097/RLU.0000000000001815

M3 - Article

VL - 42

SP - 847

EP - 852

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 11

ER -